The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients

NCT04452929 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Migraine
Migraine Without Aura
Migraine With Aura

Interventions

DRUG: Erenumab
DRUG: Placebo
DRUG: Calcitonin gene-related peptide
DRUG: Cilostazol

Sponsor

Danish Headache Center

Collaborators

[object Object]